Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
thanks a million......
I’ll give you a buzz tomorrow,Ok
thanks Gail…
I was trying to post a pic, but it didn't work...Do you know of an easy way to copy and paste a pic into our responses?
Or do I have to go through the image download thing?
hay howdy gail, caught me fooling around...he he
test
You go Girl and promote it, I was in at over a $1.00 and have been averaging down all year. I work in the automotive field and it’s selling like hotcakes, just wish the stock reflected the product.
Thanks, I just added you a personmark!
We got it all straighten out were two guys can you believe that…Lol
Hay but were all good friends…………..
Never a dull moment over here…………
OMG sorry about the spelling, I'm doing fine with my family of addicts.
I'm sure your Really Sweet,
Good to see you....sorry about the eye tricks...Lol
Hi acc, yeap i'm still in epaz, i got to beleive this babys going to pop.
Hi Reallyhurts, good to see you over here with us addicts!!!!!!!!
I like the name RealityRocks better!
Looks like good volume building here today, I’m looking for that afternoon pop!!!!!!!!!!!!!GLTA
Hi luci6, I’m not quite sure on SIRI, it’s been trading real weird. I think it will churn at this level for awhile just like the auto industry, I also think after the flippers are out it may stabilize, but who knows? Good Luck to YA!
Been a having some wild storms here in the last few days and were going to get more today. We have a lot of power outages in the area.
It would be nice to see us close above .70 today!
News Out!
Aastrom:Compassionate Use Patients In Spain Treated With Adult Stem Cell Therapy Demonstrate Jaw Bone Regeneration Enabling Dental Implants
Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that results from compassionate use treatments using Aastrom's Bone Repair Cells (BRCs) in patients suffering from severe craniofacial defects were presented at the 2nd Annual Congress of Regenerative Medicine & Stem Cell in Dalian, China. BRCs are derived from a small sample of the patient's bone marrow that is processed using Aastrom's proprietary Tissue Repair Cell (TRC) technology to generate larger numbers of stem and early progenitor cells with enhanced therapeutic potential.
In an oral presentation, Dr. Jose Mendonca, Director of the Head and Neck Surgery Unit of Hospital POLUSA in Lugo, Spain and previously a Clinical and Research Fellow in Oral and Maxillofacial Surgery at the UCLA School of Dentistry, reviewed the results of treatment with BRCs in three patients with craniofacial defects, as follows:
* The first patient was treated for severe mandibular
osteoradionecrosis, or osteonecrosis of the jaw caused by
radiation, and presented with pathological fracture and complete
numbness of the lower lip. At 12 months post-BRC treatment, the
patient displayed restored vascular function, new bone formation,
fracture consolidation and total recovery of lip numbness.
* The second patient was treated for post-traumatic mandibular
osteomyelitis and presented with massive bone loss, chronic
infection, chronic pain and total impairment of function of both
mandibular nerves. At 12 months post-BRC treatment, the patient
experienced complete functional nerve recovery and the formation of
new bone.
* The third patient was treated for iatrogenic massive bone loss in
the posterior maxilla and presented with severe oral function
impairment. At 12 months post-BRC treatment, the patient had new
bone formation in atrophic areas.
* All patients underwent a minor surgery to insert a dental implant
into the newly regenerated jaw bone. Eight weeks later, the dental
prosthesis (teeth) was attached to the implant completing the
treatment objectives with the restoration of oral function.
"The outcome of these treatments with BRCs has been very satisfactory. We observed early bone formation in the afflicted areas that eventually resulted in complete healing," said Dr. Mendonca. "Unexpected therapeutic results from treatment with BRCs include peripheral nerve regeneration or repair, new skin formation and proliferation in blood vessels in ischemic areas. The results open a promising pathway for the treatment of some patients where conventional therapies fail or do not exist."
Compassionate use of TRC-based products was authorized by the Spanish Ministry of Health. In May 2008, Aastrom announced the reprioritization of its clinical development programs to focus primarily on cardiovascular applications, thus discontinuing further patient enrollment into the U.S. Phase III ON-CORE bone regeneration clinical trial. The Company does not anticipate new clinical bone activity or reactivating the Phase III ON-CORE trial at the present time but has continued to treat patients on a compassionate use basis in Spain.
"Our bone program remains open for partnering. Encouraging compassionate use treatments such as those noted by Dr. Mendonca strengthen our bone program portfolio, especially in the EU," said Sheldon A. Schaffer, PhD, Aastrom's Vice President, Corporate Development & Intellectual Property.
At a parallel meeting, Francisco Vidal, Managing Director of Aastrom Biosciences S.L., presented a summary overview of Aastrom's technology at the 2009 4th Medical Biotech Forum in Dalian, China.
About Aastrom Biosciences, Inc.
Aastrom is a leader in the development of autologous cell products for the repair or regeneration of human tissue. The Company's proprietary Tissue Repair Cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. Aastrom's TRC-based products contain increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow collected from the patient. The TRC technology platform has positioned Aastrom to advance multiple products into clinical development. TRC-based products have been used in over 325 patients with over 10 years of positive safety data. The Company's ongoing development activities focus on applying TRC technology to cardiac and vascular tissue regeneration. The Company is currently focused on cardiovascular regeneration through a Phase II clinical trial with dilated cardiomyopathy (DCM) patients (the IMPACT-DCM trial) and a Phase IIb clinical trial with critical limb ischemia (CLI) patients (the RESTORE-CLI trial).
For more information, visit Aastrom's website at www.aastrom.com.
The Aastrom Biosciences, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3663
This document contains forward-looking statements, including without limitation, statements concerning planned clinical trials and activities and anticipated timing of clinical events, product development objectives, and potential product applications, which involve certain risks and uncertainties. The forward-looking statements are also identified through use of the words "expected," "anticipated," "planned," and other words of similar meaning. Actual results may differ significantly from the expectations contained in the forward-looking statements. Among the factors that may result in differences are potential patient accrual difficulties, clinical trial results, potential product development difficulties, the effects of competitive therapies, regulatory approval requirements, the availability of financial and other resources and the allocation of resources among different potential uses. These and other significant factors are discussed in greater detail in Aastrom's Annual Report on Form 10-K and other filings with the Securities and Exchange Commission.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Aastrom Biosciences, Inc.
Aastrom Biosciences, Inc.
Kris M. Maly
Kimberli O'Meara
(734) 930-5777
Cameron & Associates
Investors
Kevin McGrath
(212) 245-4577
Berry & Company
Media
Stephen Zoegall
(212) 253-8881
Hay Gail doing good here just sweltering in the heat today it’s over 90 with a heat index of 100. Looks like were going to get some bad thunderstorms here in awhile.
I see you guys are getting the heat too! I’ll bet you can’t wait to get home to take a dip in that pool!!!!!
Take care and rest up, we need you to be 100% for us next week!
Oh, and I’m going to call your husband and make sure he has dinner waiting for you, maybe a nice helping of steamed blue crabs, corn on the cob and a rum and a diet pepsi.
I agree that the bid stayed @ .0001 and did not change, but why all the buying?
Could it be that all of the buyers were miss lead or tricked?
I’m just trying to make sense of all the buying on the 7th.
Hay Cisco, sure is quiet around here tonight, it’s just me and you and my buddy Rum and Coke.
Had a busy day around here playing in rain and I’m finally getting a chance to kick the shoes off and relax.
Hope your relaxing over the weekend!
Cisco, I have to agree……….good to see you!
Wow, looks like I missed out on all the fun with all the new posts and pics, it was nice to see Cisco and the family and Realityhurts posting over here on Gail’s new board!
Dang I hate it when I miss out………..
It seems that I play my stocks the same way……..Lol
If that’s true why the run on the buying on the 7th?
As per the iHub trades it looks like 105,883,133 were retail.
Hi EarnestDD, how can you be sure it’s just MASSIVE DILUTION?
Can you convince me its all DILUTION and no retail buying?
I’m a newbie so can you walk me slowly through the process of your conclusion that’s this is MASSIVE DILUTION?
Thanks…..
I agree this will pop on a small amount of volume!
Just wanted to drop in and wish my fellow (ADDICTS) and wonderful weekend!!!!!!!!!! And put any losses behind you because Monday will be and new beginning!
Well let me 2nd that!!!!!!!!!
Do you still have some?
Just missed getting into CNCM first thing this morning.Dang would have been a good flip.
ok cool, hope it runs for you! GL
Be carefull on this one IHGP, look like its dilution. not sure only a guess.
Are these all buys or is the company diluting?
IHGP might be a good lotto play..
Hopefully not before the audit comes out.
Hi gang, I just wanted to let you all know that I feel lucky today in that I think were all going to make green today!!!!!!!!!!!
GLTA
Gail, just remember were here for you if you need us, Ok
Good Morning luci6, I’m keeping my fingers crossed for good luck on SIRI’s today, I hope the earnings report is positive and we get a nice pop.
Good Morning Cisco, It's good to see your post! And we all want to thank you for all you do!
Have a great day!
Thanks acc,i'll take a look at it.......
Wow, the water sure looks inviting.
Thanks for the invite; I’ll be over @ 4:00pm, Lol
GM acc, yeap were in some of the same stocks, Now if we could only get these baby’s to run we would be in great shape. When it comes to .0001 stocks the name of the game is get in and get out with a profit ASAP. Now if I could only follow that reasoning.
Have a great day!